Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland

Coordinated medical care offered in Poland for patients suffering from neurofibromatosis type 1 and related RASopathies combines complex multispecialty consultation with permanent supervision and the patient’s oriented longitudinal care. Neurofibromatosis type 1 is one of the most common single gene...

Full description

Bibliographic Details
Main Authors: Marek W. Karwacki, Mariusz Wysocki, Marta Perek-Polnik, Agnieszka Jatczak-Gaca
Format: Article
Language:English
Published: Termedia Publishing House 2019-05-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/Coordinated-medical-care-for-children-with-neurofibromatosis-type-1-and-related-RASopathies,108441,0,2.html
_version_ 1811252761511067648
author Marek W. Karwacki
Mariusz Wysocki
Marta Perek-Polnik
Agnieszka Jatczak-Gaca
author_facet Marek W. Karwacki
Mariusz Wysocki
Marta Perek-Polnik
Agnieszka Jatczak-Gaca
author_sort Marek W. Karwacki
collection DOAJ
description Coordinated medical care offered in Poland for patients suffering from neurofibromatosis type 1 and related RASopathies combines complex multispecialty consultation with permanent supervision and the patient’s oriented longitudinal care. Neurofibromatosis type 1 is one of the most common single gene disorders in the global population, observed in 1 out of 2500–3000 live births. It is a primary neoplasia disease with 100% penetration of the gene mutation but remarkable age-dependent onset of different disease signs and symptoms, outstanding clinical heterogeneity between patients even in one family and lack of genotype-phenotype correlation, a high rate of spontaneous mutation exceeding 50%, and multiple comorbidities among which increased risk of malignancy is the most important. Medical practice proved that not only patient-oriented complex but also coordinated care provided in centers of competence is indispensable for patients and the families and provides a sense of medical security to them in conjunction with public health costs rationalization.
first_indexed 2024-04-12T16:40:31Z
format Article
id doaj.art-744df58249844f699e5b3a411f740f3b
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-04-12T16:40:31Z
publishDate 2019-05-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-744df58249844f699e5b3a411f740f3b2022-12-22T03:24:50ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512019-05-011751221123110.5114/aoms.2019.85143108441Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in PolandMarek W. Karwacki0Mariusz Wysocki1Marta Perek-Polnik2Agnieszka Jatczak-Gaca3Coordinated Care Center for Neurofibromatoses and related RASopathies, Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, PolandDepartment of Paediatrics, Haematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, PolandNeuro-oncology Division, Department of Oncology, The Children’s Memorial Health Institute, Warsaw, PolandDepartment of Paediatrics, Haematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, PolandCoordinated medical care offered in Poland for patients suffering from neurofibromatosis type 1 and related RASopathies combines complex multispecialty consultation with permanent supervision and the patient’s oriented longitudinal care. Neurofibromatosis type 1 is one of the most common single gene disorders in the global population, observed in 1 out of 2500–3000 live births. It is a primary neoplasia disease with 100% penetration of the gene mutation but remarkable age-dependent onset of different disease signs and symptoms, outstanding clinical heterogeneity between patients even in one family and lack of genotype-phenotype correlation, a high rate of spontaneous mutation exceeding 50%, and multiple comorbidities among which increased risk of malignancy is the most important. Medical practice proved that not only patient-oriented complex but also coordinated care provided in centers of competence is indispensable for patients and the families and provides a sense of medical security to them in conjunction with public health costs rationalization.https://www.archivesofmedicalscience.com/Coordinated-medical-care-for-children-with-neurofibromatosis-type-1-and-related-RASopathies,108441,0,2.htmlneurofibromatosescoordinated medical carenational standard
spellingShingle Marek W. Karwacki
Mariusz Wysocki
Marta Perek-Polnik
Agnieszka Jatczak-Gaca
Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland
Archives of Medical Science
neurofibromatoses
coordinated medical care
national standard
title Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland
title_full Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland
title_fullStr Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland
title_full_unstemmed Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland
title_short Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland
title_sort coordinated medical care for children with neurofibromatosis type 1 and related rasopathies in poland
topic neurofibromatoses
coordinated medical care
national standard
url https://www.archivesofmedicalscience.com/Coordinated-medical-care-for-children-with-neurofibromatosis-type-1-and-related-RASopathies,108441,0,2.html
work_keys_str_mv AT marekwkarwacki coordinatedmedicalcareforchildrenwithneurofibromatosistype1andrelatedrasopathiesinpoland
AT mariuszwysocki coordinatedmedicalcareforchildrenwithneurofibromatosistype1andrelatedrasopathiesinpoland
AT martaperekpolnik coordinatedmedicalcareforchildrenwithneurofibromatosistype1andrelatedrasopathiesinpoland
AT agnieszkajatczakgaca coordinatedmedicalcareforchildrenwithneurofibromatosistype1andrelatedrasopathiesinpoland